Perspective Therapeutics (CATX) Non-Current Deferred Tax Liability (2023 - 2025)
Historic Non-Current Deferred Tax Liability for Perspective Therapeutics (CATX) over the last 3 years, with Q3 2025 value amounting to $2.5 million.
- Perspective Therapeutics' Non-Current Deferred Tax Liability fell 4566.64% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year decrease of 4566.64%. This contributed to the annual value of $2.5 million for FY2024, which is 4566.64% down from last year.
- Per Perspective Therapeutics' latest filing, its Non-Current Deferred Tax Liability stood at $2.5 million for Q3 2025, which was down 4566.64% from $2.5 million recorded in Q2 2025.
- In the past 5 years, Perspective Therapeutics' Non-Current Deferred Tax Liability registered a high of $4.6 million during Q4 2023, and its lowest value of $2.5 million during Q4 2024.
- For the 3-year period, Perspective Therapeutics' Non-Current Deferred Tax Liability averaged around $3.5 million, with its median value being $3.5 million (2023).
- Examining YoY changes over the last 5 years, Perspective Therapeutics' Non-Current Deferred Tax Liability showed a top increase of 4566.64% in 2024 and a maximum decrease of 4566.64% in 2024.
- Quarter analysis of 3 years shows Perspective Therapeutics' Non-Current Deferred Tax Liability stood at $4.6 million in 2023, then crashed by 45.67% to $2.5 million in 2024, then changed by 0.0% to $2.5 million in 2025.
- Its Non-Current Deferred Tax Liability was $2.5 million in Q3 2025, compared to $2.5 million in Q2 2025 and $2.5 million in Q1 2025.